Michael King
Stock Analyst at EF Hutton
(0)
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
APLM Apollomics | Maintains: Buy | 1100 650 | 5.69 | 11323.55% | 4 | Apr 1, 2024 | |
SONN Sonnet BioTherapeuti... | Assumes: Buy | 1180 | 3.07 | 38310.42% | 7 | Aug 23, 2023 | |
LTRN Lantern Pharma | Reiterates: Buy | 11 | 4.33 | 154.04% | 10 | Aug 10, 2023 | |
BMEA Biomea Fusion | Reiterates: Buy | 32 | 1.52 | 2005.26% | 11 | Jun 26, 2023 | |
JSPR Jasper Therapeutics | Reiterates: Buy | 69 | 2.62 | 2514.5% | 10 | Jun 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Buy | 200 | 11.08 | 1705.05% | 7 | May 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Buy | 9 | 1.18 | 603.39% | 6 | May 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 862 | 546.18 | 57.82% | 11 | May 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 24 | 37.43 | -35.88% | 10 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 10 17 | n/a | n/a | 3 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 166 | 4.27 | 3787.59% | 7 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 42 | 7 | 500% | 5 | Feb 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 304 | 434.89 | -30.1% | 2 | Feb 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 123 116 | 10.75 | 979.07% | 6 | Feb 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 11 | 3.33 | 209.31% | 2 | Dec 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 500 560 | n/a | n/a | 2 | Mar 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 24 | 31.47 | -23.74% | 1 | Mar 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 1000 800 | n/a | n/a | 2 | Mar 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 43 46 | 19.97 | 130.35% | 3 | Mar 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 98 96 | 35.1 | 173.5% | 6 | Mar 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 10500 5250 | n/a | n/a | 2 | Jan 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 36 | 0.68 | 5194.12% | 1 | Jan 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 12 | n/a | n/a | 1 | Dec 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 25 31 | 10.93 | 183.62% | 2 | Nov 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 9 | n/a | n/a | 1 | Oct 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Outperform | 180 160 | n/a | n/a | 4 | Oct 18, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Outperform | 1088 544 | n/a | n/a | 2 | Jun 13, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Outperform | 33 36 | 638.76 | -94.36% | 2 | Nov 13, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Market Outperform | 38 | 25.59 | 48.5% | 1 | Oct 23, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | n/a | n/a | n/a | 1 | Aug 29, 2017 |